Clinical trial
A Study to Evaluate the Substance Balance of [14C] ZX-7101A in Healthy Adult Male Subjects in China
NCT05720091 is registered in ClinicalTrials.gov with Nanjing Zenshine Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Substance Balance of [14C] ZX-7101A in Healthy Adult Male Subjects in China
- Lead sponsor
- Nanjing Zenshine Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 14, 2023
- Completion date
- July 25, 2023
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.